155 related articles for article (PubMed ID: 36982170)
1. A
Jiang W; Ouyang X; Jiang C; Yin L; Yao Q; Pei X; Ji Z; Li M; Song S; Yang W; Huang S; Yang H; Shan B
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982170
[TBL] [Abstract][Full Text] [Related]
2. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
3. Elevated Expression of NOTCH1 Associates with Lymph Node Metastasis of Gastric Cancer and Knock-Down of NOTCH1 Attenuates Tumor Cell Progression.
Huang B; Jin G; Qu C; Ma H; Ding C; Zhang Y; Liu W; Li W
Med Sci Monit; 2019 Dec; 25():9939-9948. PubMed ID: 31874951
[TBL] [Abstract][Full Text] [Related]
4. Notch1 receptor as a marker of lymph node metastases in papillary thyroid cancer.
Park HS; Jung CK; Lee SH; Chae BJ; Lim DJ; Park WC; Song BJ; Kim JS; Jung SS; Bae JS
Cancer Sci; 2012 Feb; 103(2):305-9. PubMed ID: 22118425
[TBL] [Abstract][Full Text] [Related]
5. Metastasis to para-aortic lymph nodes cephalad to the renal veins in patients with ovarian cancer.
Komiyama S; Nagashima M; Taniguchi T; Rikitake T; Morita M
World J Surg Oncol; 2020 Apr; 18(1):64. PubMed ID: 32238145
[TBL] [Abstract][Full Text] [Related]
6. AEG -1 overexpression: a novel indicator for peritoneal dissemination and lymph node metastasis in epithelial ovarian cancers.
Li C; Liu J; Lu R; Yu G; Wang X; Zhao Y; Song H; Lin P; Sun X; Yu X; Zhang Y; Ning X; Geng J
Int J Gynecol Cancer; 2011 May; 21(4):602-8. PubMed ID: 21543927
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA‑455 inhibits cell proliferation and invasion of epithelial ovarian cancer by directly targeting Notch1.
Xu L; Li H; Su L; Lu Q; Liu Z
Mol Med Rep; 2017 Dec; 16(6):9777-9785. PubMed ID: 29039517
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA GClnc1 knockdown suppresses progression of epithelial ovarian cancer by recruiting FOXC2 to disrupt the NOTCH1/NF-κB/Snail pathway.
Wu D; Ke Y; Xiao R; Liu J; Li Q; Wang Y
Exp Cell Res; 2021 Feb; 399(1):112422. PubMed ID: 33338479
[TBL] [Abstract][Full Text] [Related]
9. [Risk factors for retroperitoneal lymph node metastasis in ovarian cancer].
Akiyama M; Takahashi Y; Hirose M; Yamamoto Y; Ishiguro T; Noda Y
Nihon Sanka Fujinka Gakkai Zasshi; 1994 Mar; 46(3):260-4. PubMed ID: 8133137
[TBL] [Abstract][Full Text] [Related]
10. [Establishment of human ovarian carcinoma cell lines with directional highly lymphatic metastasis and study of their biological characteristics].
Ruan HY; Li DR; Li L; Guan X; Zhang W
Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):482-6. PubMed ID: 17961340
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of long noncoding RNA DLX6-AS1 defines good prognosis and inhibits proliferation and metastasis in human epithelial ovarian cancer cells via Notch signaling pathway.
Zhao J; Liu HR
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3243-3252. PubMed ID: 31081076
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric analysis of lymph node metastases in advanced ovarian cancer: clinical and biologic significance.
Kimball RE; Schlaerth JB; Kute TE; Schlaerth AC; Santoso J; Ballon SC; Spirtos NM
Am J Obstet Gynecol; 1997 Jun; 176(6):1319-26; discussion 1326-7. PubMed ID: 9215191
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Factors Affecting Lymph Node Metastasis in Clinical Stage I-II Epithelial Ovarian Cancer.
Erdem B; Yüksel IT; Peker N; Ulukent SC; Aşıcıoğlu O; Özaydin IY; Ülker V; Akbayir O
Oncol Res Treat; 2018; 41(7-8):444-448. PubMed ID: 29975960
[TBL] [Abstract][Full Text] [Related]
14. Lymph node-positive stage IIIC ovarian cancer: a separate entity?
Berek JS
Int J Gynecol Cancer; 2009 Dec; 19 Suppl 2():S18-20. PubMed ID: 19955908
[TBL] [Abstract][Full Text] [Related]
15. Impact of lymph node staging in presumed early-stage ovarian carcinoma.
Rodrigues Teixeira F; Vertematti de Castro V; Chaves Faloppa C; Mantoan H; Yuri Kumagai L; Narcizo Oliveira Menezes A; Badiglian-Filho L; De Brot L; Tirapelli Goncalves B; Paiva Gadelha Guimaraes A; Baiocchi G
Eur J Obstet Gynecol Reprod Biol; 2022 Nov; 278():6-10. PubMed ID: 36108452
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.
Powless CA; Aletti GD; Bakkum-Gamez JN; Cliby WA
Gynecol Oncol; 2011 Sep; 122(3):536-40. PubMed ID: 21636114
[TBL] [Abstract][Full Text] [Related]
17. Distribution pattern and risk factors of pelvic and para-aortic lymph node metastasis in epithelial ovarian carcinoma.
Tsumura N; Sakuragi N; Hareyama H; Satoh C; Oikawa M; Yamada H; Yamamoto R; Okuyama K; Fujino T; Sagawa T; Fujimoto S
Int J Cancer; 1998 Oct; 79(5):526-30. PubMed ID: 9761124
[TBL] [Abstract][Full Text] [Related]
18. SPARC suppresses lymph node metastasis by regulating the expression of VEGFs in ovarian carcinoma.
Peng F; Zhong Y; Liu Y; Zhang Y; Xie Y; Lu Y; Zhang X; Li D
Int J Oncol; 2017 Dec; 51(6):1920-1928. PubMed ID: 29075785
[TBL] [Abstract][Full Text] [Related]
19. Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall.
Recine MA; Deavers MT; Middleton LP; Silva EG; Malpica A
Am J Surg Pathol; 2004 Dec; 28(12):1646-51. PubMed ID: 15577686
[TBL] [Abstract][Full Text] [Related]
20. Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer.
Negishi H; Takeda M; Fujimoto T; Todo Y; Ebina Y; Watari H; Yamamoto R; Minakami H; Sakuragi N
Gynecol Oncol; 2004 Jul; 94(1):161-6. PubMed ID: 15262135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
